Tylosin tartrate, a macrolide antibiotic, is highly soluble in water. Compared with tylosin, it features better intestinal absorption, rapid in-vivo diffusion, and high blood drug concentration, and is mostly used for the prevention and treatment of mycoplasma diseases in pigs and poultry. It can prevent and treat swine dysentery, colitis, ileitis, and necrotic enteritis, maintain body weight gain during atrophic rhinitis, reduce the incidence of diarrhea and edema disease in newborn and weaned piglets caused by Escherichia coli, control swine asthma caused by mycoplasma infection, chronic respiratory diseases in chickens, and alleviate stress responses in livestock and poultry. It can also prevent and treat secondary infections of sensitive bacteria in livestock and poultry after outbreaks of viral diseases.

The formula is scientific, and it synergizes with special excipients and synergists, increasing the effect by 8-10 times compared with pure active pharmaceutical ingredients.

Using long-acting sustained-release and targeting technologies, it is rapidly absorbed after oral administration, widely distributed in the body, and the effective blood concentration lasts for a long time.

It is a special antibiotic for livestock and poultry, featuring high efficiency, quick action, safety, and no toxic side effects.

With significant anti-mycoplasma effects, it is the first-choice drug for mycoplasma infectious diseases in livestock and poultry.

It has a significant "hepato-enteric circulation", higher bioavailability, and the post-drug effect can continue for 2-6 hours.

With significant growth-promoting effects, it can significantly promote animal growth, shorten the growth cycle, and improve feed conversion ratio.